Sino Biopharmaceutical
1177.HK
$0.35
Share price
1.09%
Change (1 day)
-35.19%
Change (1 year)
Categories
Sino Biopharmaceutical
is a company based on Hong Kong that does R&D, production and sales of pharmaceuticals.
Revenue for Sino Biopharmaceutical (1177.HK)
Revenue in 2021 (TTM): $3.85 B
According to Sino Biopharmaceutical's latest financial reports the company's current revenue (TTM) is $3.85 B. In 2020 the company made a revenue of $3.43 B a decrease over the years 2019 revenue that were of $3.50 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Sino Biopharmaceutical from 2011 to 2021
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2021 (TTM) | $3.85 B | 12.18% |
| 2020 | $3.43 B | -1.95% |
| 2019 | $3.50 B | 11.88% |
| 2018 | $3.13 B | 41.79% |
| 2017 | $2.20 B | 3.71% |
| 2016 | $2.12 B | 10.16% |
| 2015 | $1.93 B | 20.77% |
| 2014 | $1.60 B | 26.69% |
| 2013 | $1.26 B | 18.54% |
| 2012 | $1.06 B | 46.12% |
| 2011 | $0.72 B |